Semaglutide has emerged as a novel treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and reducing glucagon https://susanqdvi685167.bluxeblog.com/67778062/understanding-semaglutide-a-comprehensive-guide